249 related articles for article (PubMed ID: 32167394)
1. Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes.
Yoo JH; Choi MS; Ahn J; Park SW; Kim Y; Hur KY; Jin SM; Kim G; Kim JH
Diabetes Technol Ther; 2020 Oct; 22(10):768-776. PubMed ID: 32167394
[No Abstract] [Full Text] [Related]
2. The Association Between Continuous Glucose Monitoring-Derived Metrics and Cardiovascular Autonomic Neuropathy in Outpatients with Type 2 Diabetes.
Kim MY; Kim G; Park JY; Choi MS; Jun JE; Lee YB; Jin SM; Hur KY; Kim JH
Diabetes Technol Ther; 2021 Jun; 23(6):434-442. PubMed ID: 33523771
[No Abstract] [Full Text] [Related]
3. Continuous glucose monitoring metrics following sub-Tenon's injection of triamcinolone acetonide for diabetic macular edema.
Sotani-Ogawa R; Kusuhara S; Hirota Y; Kim KW; Matsumiya W; Ogawa W; Nakamura M
Graefes Arch Clin Exp Ophthalmol; 2024 Feb; 262(2):449-456. PubMed ID: 37864636
[TBL] [Abstract][Full Text] [Related]
4. Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes.
Wakasugi S; Mita T; Katakami N; Okada Y; Yoshii H; Osonoi T; Nishida K; Shiraiwa T; Torimoto K; Kurozumi A; Gosho M; Shimomura I; Watada H
BMJ Open Diabetes Res Care; 2021 Apr; 9(1):. PubMed ID: 33879513
[TBL] [Abstract][Full Text] [Related]
5. Association of Continuous Glucose Monitoring Metrics With Pregnancy Outcomes in Patients With Preexisting Diabetes.
Sanusi AA; Xue Y; McIlwraith C; Howard H; Brocato BE; Casey B; Szychowski JM; Battarbee AN
Diabetes Care; 2024 Jan; 47(1):89-96. PubMed ID: 37782847
[TBL] [Abstract][Full Text] [Related]
6. Characterising frailty, metrics of continuous glucose monitoring, and mortality hazards in older adults with type 2 diabetes on insulin therapy (HARE): a prospective, observational cohort study.
Fung E; Lui LT; Huang L; Cheng KF; Lau GHW; Chung YT; Ahmadabadi BN; Xie S; Lee JSW; Hui E; So WY; Sung JJY; King I; Goggins WB; Chan Q; Järvelin MR; Ma RCW; Chow E; Kwok T
Lancet Healthy Longev; 2021 Nov; 2(11):e724-e735. PubMed ID: 36098029
[TBL] [Abstract][Full Text] [Related]
7. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
Rodbard D
Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
[TBL] [Abstract][Full Text] [Related]
8. Association between continuous glucose monitoring-derived glycemic control indices and urinary biomarkers of diabetic kidney disease: Hyogo Diabetes Hypoglycemia Cognition Complications study.
Takagi A; Kusunoki Y; Ohigashi M; Osugi K; Inoue C; Inoue M; Tsunoda T; Kadoya M; Konishi K; Katsuno T; Koyama H;
Acta Diabetol; 2024 Apr; 61(4):413-423. PubMed ID: 38006524
[TBL] [Abstract][Full Text] [Related]
9. High Glycemic Variability Is Associated with Worse Continuous Glucose Monitoring Metrics in Children and Adolescents with Type 1 Diabetes.
Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
Horm Res Paediatr; 2021; 94(9-10):369-373. PubMed ID: 34915493
[TBL] [Abstract][Full Text] [Related]
10. Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study.
Shah VN; Kanapka LG; Akturk HK; Polsky S; Forlenza GP; Kollman C; Beck RW; Snell-Bergeon JK
Diabetes Technol Ther; 2024 Apr; 26(4):246-251. PubMed ID: 38133643
[No Abstract] [Full Text] [Related]
11. Relationship between key continuous glucose monitoring-derived metrics and specific cognitive domains in patients with type 2 diabetes mellitus.
Dong S; Wang L; Zhao C; Zhang R; Gao Z; Jiang L; Guo Y; Zhou H; Xu S
BMC Neurol; 2023 May; 23(1):200. PubMed ID: 37210479
[TBL] [Abstract][Full Text] [Related]
12. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
[TBL] [Abstract][Full Text] [Related]
13. Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
Lu J; Ma X; Zhou J; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Vigersky RA; Jia W
Diabetes Care; 2018 Nov; 41(11):2370-2376. PubMed ID: 30201847
[TBL] [Abstract][Full Text] [Related]
14. Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control.
Yoo JH; Kim JH
Diabetes Metab J; 2020 Dec; 44(6):828-839. PubMed ID: 33389957
[TBL] [Abstract][Full Text] [Related]
15. Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review.
Raj R; Mishra R; Jha N; Joshi V; Correa R; Kern PA
BMJ Open Diabetes Res Care; 2022 Jan; 10(1):. PubMed ID: 34980591
[TBL] [Abstract][Full Text] [Related]
16. Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study
Préau Y; Galie S; Schaepelynck P; Armand M; Raccah D
Sensors (Basel); 2021 Sep; 21(18):. PubMed ID: 34577338
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality.
Kim JY; Yoo JH; Kim JH
Diabetes Technol Ther; 2023 Dec; 25(12):883-892. PubMed ID: 37668665
[No Abstract] [Full Text] [Related]
18. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
Beck RW; Bergenstal RM; Cheng P; Kollman C; Carlson AL; Johnson ML; Rodbard D
J Diabetes Sci Technol; 2019 Jul; 13(4):614-626. PubMed ID: 30636519
[TBL] [Abstract][Full Text] [Related]
19. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown.
Brener A; Mazor-Aronovitch K; Rachmiel M; Levek N; Barash G; Pinhas-Hamiel O; Lebenthal Y; Landau Z
Acta Diabetol; 2020 Dec; 57(12):1511-1517. PubMed ID: 33026497
[TBL] [Abstract][Full Text] [Related]
20. Albuminuria, glycemic variability and effect of flash glucose monitoring based decision making on short term glycemic variability in Indian type 2 diabetes patients: Indi-GlyVar study.
Nathiya D; Singh M; Suman S; Bareth H; Pal N; Jain A; Tomar BS
Front Endocrinol (Lausanne); 2022; 13():1011411. PubMed ID: 36465630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
